Momentum Biotechnologies Acquires OmicScouts GmbH
March 5, 2025
Momentum Biotechnologies, a mass spectrometry–focused contract research organization (CRO) based in Billerica, Massachusetts, has acquired Munich-based OmicScouts GmbH to integrate proteomics capabilities into its drug-discovery service offering. The deal expands Momentum's technical services (chemoproteomics and validated proteomic assays) and provides immediate geographic presence in Europe.
- Buyers
- Momentum Biotechnologies
- Targets
- OmicScouts GmbH
- Industry
- Biotechnology
- Location
- Bavaria, Germany
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
10x Genomics Acquires Proteintech Genomics to Expand Proteomics Capabilities
June 10, 2026
Biotechnology
10x Genomics announced it has acquired Proteintech Genomics, a division within Proteintech Group, to expand its proteomics capabilities for single-cell and spatial multiomics workflows on 10x platforms. The deal adds Proteintech Genomics’ Human Discovery Panel technology and supports 10x’s strategy of integrating transcriptomic and proteomic measurements, including capabilities planned for its Atera platform. Financial terms were not disclosed.
-
PMG Acquires Momentum Commerce
June 11, 2025
Marketing & Advertising
PMG, a global independent marketing services and technology company, has acquired Momentum Commerce, a retail media and marketplace intelligence firm, and will fully integrate Momentum into the PMG brand. The deal adds Momentum’s 45-person team and its Velocity platform—tracking millions of products and brands—strengthening PMG’s commerce capability to help enterprise brands drive growth across retail and marketplace channels.
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
Calibre Scientific Acquires MoBiTec GmbH
January 15, 2024
Biotechnology
Calibre Scientific has acquired MoBiTec GmbH, a German supplier of consumables and services for molecular and cell biology. MoBiTec will be integrated into BIOZOL Diagnostica GmbH (a Calibre subsidiary) to broaden BIOZOL's product range and strengthen the group's capabilities and sales presence in the DACH research, diagnostics, and pharmaceutical markets.
-
Sygnature Discovery Acquires NuChem Sciences
August 1, 2023
Biotechnology
UK-based integrated drug discovery CRO Sygnature Discovery has acquired Montreal-headquartered NuChem Sciences, one of North America's largest discovery contract research organisations. The deal expands Sygnature's global footprint and capabilities in medicinal chemistry, DMPK, structural biology and in vitro/in vivo pharmacology, strengthening its position in the North American market.
-
Biosynth Carbosynth Acquires Pepscan
July 4, 2022
Biotechnology
Biosynth Carbosynth, a KKR- and Ampersand-backed supplier of materials to the life-sciences industry, has acquired Pepscan, a Netherlands-based peptide discovery, optimization and GMP peptide manufacturing specialist. The deal adds Pepscan’s proprietary CLIPS technology and epitope-mapping capabilities to Biosynth’s peptide capabilities (including vivitide) to form a new global Peptide division serving pharma, biotech, diagnostics and cosmetics customers.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.